CRIS Current Research Information System

PIRONI, LORIS
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.122
AS - Asia 9.021
EU - Europa 6.526
AF - Africa 602
SA - Sud America 599
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.892
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.006
SG - Singapore 2.595
CN - Cina 2.351
VN - Vietnam 2.127
GB - Regno Unito 1.725
IT - Italia 1.264
DE - Germania 797
HK - Hong Kong 580
FR - Francia 484
IN - India 458
BR - Brasile 417
SE - Svezia 417
RU - Federazione Russa 376
UA - Ucraina 282
KR - Corea 252
IE - Irlanda 242
ZA - Sudafrica 223
FI - Finlandia 220
JP - Giappone 199
NL - Olanda 187
EE - Estonia 114
CH - Svizzera 98
CI - Costa d'Avorio 87
TG - Togo 87
SC - Seychelles 82
AR - Argentina 72
ID - Indonesia 54
CA - Canada 53
JO - Giordania 50
BG - Bulgaria 48
AT - Austria 47
BE - Belgio 45
ES - Italia 45
MX - Messico 43
BD - Bangladesh 41
PH - Filippine 39
PL - Polonia 39
NG - Nigeria 36
TH - Thailandia 36
TW - Taiwan 34
PE - Perù 33
TR - Turchia 33
PK - Pakistan 32
IQ - Iraq 27
EC - Ecuador 24
EG - Egitto 24
IR - Iran 22
SA - Arabia Saudita 19
CO - Colombia 15
AU - Australia 14
MA - Marocco 14
CL - Cile 13
RO - Romania 13
GR - Grecia 12
CZ - Repubblica Ceca 11
LT - Lituania 11
UZ - Uzbekistan 11
PY - Paraguay 10
ET - Etiopia 9
LB - Libano 8
NP - Nepal 8
PT - Portogallo 8
VE - Venezuela 8
HR - Croazia 7
KE - Kenya 7
MY - Malesia 7
AZ - Azerbaigian 6
DO - Repubblica Dominicana 6
NO - Norvegia 6
DZ - Algeria 5
MD - Moldavia 5
SI - Slovenia 5
DK - Danimarca 4
HU - Ungheria 4
IL - Israele 4
KZ - Kazakistan 4
MG - Madagascar 4
TN - Tunisia 4
UY - Uruguay 4
AL - Albania 3
BH - Bahrain 3
BO - Bolivia 3
EU - Europa 3
KG - Kirghizistan 3
OM - Oman 3
PA - Panama 3
RS - Serbia 3
AO - Angola 2
CR - Costa Rica 2
FJ - Figi 2
GH - Ghana 2
JM - Giamaica 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LY - Libia 2
ME - Montenegro 2
MU - Mauritius 2
RW - Ruanda 2
SN - Senegal 2
Totale 26.863
Salva come PNG Salva come JPEG
Città #
Singapore 1.801
Southend 1.506
Ashburn 1.080
Fairfield 1.061
Chandler 630
Hefei 552
San Jose 549
Hong Kong 547
Ho Chi Minh City 539
Woodbridge 535
Seattle 457
Hanoi 447
Wilmington 429
Houston 428
Cambridge 421
Santa Clara 406
Princeton 339
Bologna 266
Ann Arbor 249
Boardman 245
Dublin 242
Seoul 223
Beijing 215
Helsinki 189
Lauterbourg 179
Council Bluffs 158
Dong Ket 158
Los Angeles 156
Jacksonville 150
Tokyo 148
Westminster 132
Nanjing 126
Dallas 125
Johannesburg 113
Padova 112
Berlin 102
Abidjan 87
Lomé 87
Buffalo 82
Milan 77
Haiphong 76
New York 74
Jinan 72
Saint Petersburg 69
Shenyang 67
Guangzhou 66
Da Nang 59
San Diego 58
Munich 57
Redondo Beach 56
Bengaluru 55
Shanghai 53
Frankfurt am Main 48
Redmond 48
Sofia 48
Amman 47
Bern 46
Dearborn 44
São Paulo 44
Changsha 43
Turin 40
Des Moines 39
Medford 39
Rome 39
Hebei 38
Nanchang 38
Tianjin 38
The Dalles 34
Amsterdam 33
Florence 32
Abeokuta 31
Brussels 31
Phoenix 31
Hải Dương 30
Hangzhou 29
Nuremberg 29
Zhengzhou 29
London 28
Chicago 27
Jakarta 27
Warsaw 26
Shenzhen 25
Vienna 24
Can Tho 23
Paris 23
Mülheim 22
Olalla 22
Cesena 21
Chennai 21
Jiaxing 21
Lima 21
Ninh Bình 21
Norwalk 21
Redwood City 21
San Francisco 20
Thái Bình 20
Tongling 20
Bắc Ninh 19
Falls Church 19
Lappeenranta 19
Totale 17.569
Salva come PNG Salva come JPEG
Nome #
Development of home artificial nutrition in Italy over a seven year period: 2005–2012 380
Dialisi peritoneale (DP) e nutrizione parenterale (NP) nella teraoia della MNGIE: un caso clinico 335
Liver transplantation for mitochondrial neurogastrointestinal encephalomyopathy 281
ESPEN micronutrient guideline 265
Glutamine Supplementation as a Novel Metabolic Therapeutic Strategy for LIG3-Dependent Chronic Intestinal Pseudo-obstruction 264
Cerebral Mitochondrial Microangiopathy Leads to Leukoencephalopathy in Mitochondrial Neurogastrointestinal Encephalopathy 260
Evidence of enteric angiopathy and neuromuscular hypoxia in patients with mitochondrial neurogastrointestinal encephalomyopathy 251
Prevalenza della Nutrizione Artificiale Domiciliare in Italia nel 2005: indagine epidemiologica SINPE 247
Comprehensive surgical intestinal rescue and transplantation program in adult patients: Bologna experience. 246
The gut microbiota in adults with chronic intestinal failure 241
ESPEN practical guideline: Home enteral nutrition 241
Determinants of weight, psychological status, food contemplation and lifestyle changes in patients with obesity during the COVID-19 lockdown: a nationwide survey using multiple correspondence analysis 231
La Nutrizione Artificiale: il progetto della regione Emilia-Romagna 221
Anatomical Laser Microdissection of the Ileum Reveals mtDNA Depletion Recovery in A Mitochondrial Neuro-Gastrointestinal Encephalomyopathy (MNGIE) Patient Receiving Liver Transplant 218
Long-term endoscopic follow-up in small bowel transplant recipients: single-center series. 218
Liver as a Source for Thymidine Phosphorylase Replacement in Mitochondrial Neurogastrointestinal Encephalomyopathy 218
Multimodal Surgical Approach for Adult Patients With Chronic Intestinal Pseudo-Obstruction: Clinical and Psychosocial Long-term Outcomes 217
Definitions of intestinal failure and the short bowel syndrome 213
ITA-MNGIE: an Italian regional and national survey for mitochondrial neuro-gastro-intestinal encephalomyopathy. 208
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): Position paper on diagnosis, prognosis, and treatment by the MNGIE International Network 206
Italian experience in adult clinical intestinal and multivisceral transplantation: 6 years later. 202
ESPEN practical guideline: Home parenteral nutrition 199
Liver transplantation in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): clinical long-term follow-up and pathogenic implications 193
Acute intestinal failure: International multicenter point-of-prevalence study 192
Daclizumab and Alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period. 192
Eating habits in patients affected by metabolic syndrome and liver disease (hepatitis, cirrhosis and liver transplant) 192
Assessment of Intestinal Failure Associated Liver Disease according to different diagnostic criteria 190
Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period. 189
Octreotide in the outpatient therapy of cirrhotic chylous ascites: a case report. 188
Clinical classification of adult patients with chronic intestinal failure due to benign disease: An international multicenter cross-sectional survey 188
Bone mineral density in patients on home parenteral nutrition: a follow-up study. 187
Malnutrition and nutritional therapy in patients with SARS-CoV-2 disease 187
Liver tissue: a proof-of-concept study for OLT in MNGIE patients 186
Italian guidelines for intestinal transplantation: potential candidates among the adult patients managed by a medical referral center for chronic intestinal failure. 175
Two novel PRNP truncating mutations broaden the spectrum of prion amyloidosis 175
Plasma citrulline after small bowel transplantation: Effect of time from transplantation, acute cellular rejection, and renal failure 172
Real-world prevalence of metabolic associated fatty liver disease (MAFLD) and fibrotic-non-alcoholic steatohepatitis (NASH) in patients with obesity (PwO) in an outpatient specialist clinic in Italy 171
Candidates for intestinal transplantation: a multicenter survey in Europe 171
Functional lipidomics in patients on home parenteral nutrition: Effect of lipid emulsions 171
Liraglutide 3.0 mg and mental health: can psychiatric symptoms be associated to adherence to therapy? Insights from a clinical audit 170
Capsule endoscopy revealing small-intestinal lymphangiectasia and GI stromal tumor polyps in neurofibromatosis type 1. 169
Rejection episodes and 3-year graft survival under sirolimus and tacrolimus treatment after adult intestinal transplantation. 169
Iodine nutrition in adults on long-term home parenteral nutrition 169
The SF-36 instrument for the follow-up of health-related quality-of-life assessment of patients undergoing home parenteral nutrition for benign disease. 168
Impact of induction therapy on bacterial infections and long-term outcome in adult intestinal and multivisceral transplantation: a comparison of two different induction protocols: daclizumab vs. alemtuzumab. 167
Real-life prevalence of Metabolic Associated Fatty Liver Disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in a tertiary obesity clinic in Italy 164
Outcome of kidney function in adults on long-term home parenteral nutrition for chronic intestinal failure 164
Effect of age on native kidney function after adult intestinal transplants on long-term follow-up 163
Surgery for post-operative entero-cutaneous fistulas: Is bowel resection plus primary anastomosis without stoma a safe option to avoid early recurrence? Report on 20 cases by a single center and systematic review of the literature 163
Fish oil-based emulsion for the treatment of parenteral nutrition associated liver disease in an adult patient 162
Intravenous lipids in home parenteral nutrition 162
Immunonutrition in patients who underwent major abdominal surgery: A comprehensive systematic review and component network metanalysis using GRADE and CINeMA approaches 160
Liver transplant reverses biochemical imbalance in mitochondrial neurogastrointestinal encephalomyopathy 160
Results of intestinal and multivisceral transplantation in adult patients: Italian experience. 160
Chronic Intestinal Failure in Children: An International Multicenter Cross-Sectional Survey 158
Alemtuzumab plus cyclosporine treatment of the autoimmune hemolytic anemia in an adult bowel transplant 157
Risk of binge eating disorder in patients with metabolic dysfunction-associated steatotic liver disease 156
Recovery from liver dysfunction after adult isolated intestinal transplantation without liver grafting. 155
A cross-sectional study on the prevalence of eating disorders in liver transplanted patients with type 2 diabetes and/or overweight/obesity 154
Cholestasis induced by total parenteral nutrition 154
Twenty-five consecutive isolated intestinal transplants in adult patients: a five-yr clinical experience. 154
Burden of non-alcoholic fatty liver disease and usefulness of non-invasive tests to identify advanced liver disease in patients with type 2 diabetes mellitus: interimanalysis of an Italian prospective multicentre study 152
Iodine status in intestinal failure in adults 152
Three-year experience in clinical intestinal transplantation 152
Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort 152
Disease-related intestinal transplant in adults: results from a single center 150
Assessment of quality of life on home parenteral nutrition and after intestinal transplantation using treatment-specific questionnaires 149
Dati preliminari sullo studio della sintomatologia ortoressica tra pazienti diabetici affetti da epatopatia. 149
Symptoms of SARS-CoV-2 infection and vaccine status of sixty-seven adult patients affected by inherited metabolic diseases: a phone survey 147
Use of teduglutide in adults with short bowel syndrome–associated intestinal failure 143
Characteristics of adult patients with chronic intestinal failure due to short bowel syndrome: An international multicenter survey 143
Clinical approach to the management of Intestinal Failure Associated Liver Disease (IFALD) in adults: A position paper from the Home Artificial Nutrition and Chronic Intestinal Failure Special Interest Group of ESPEN 142
Renal function in patients on long-term home parenteral nutrition and in intestinal transplant recipients 141
The complex relationship between magnesium and serum parathyroid hormone: a study in patients with chronic intestinal failure 140
Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease 140
Intestinal failure associated liver disease after weaning off home parenteral nutrition: a 12-month follow up 139
Total parenteral nutrition-related gastroenterological complications 139
Bone mineral density and bone turnover after successful intestinal transplant in adult recipients: a preliminary report 139
Five-year survival and causes of death in patients on home parenteral nutrition for severe chronic and benign intestinal failure 138
In vivo assessment of skeletal muscle mithocondrial function in patients on long-term home parenteral nutrition (HPN). 137
Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation 137
Nutrition and elderly cancer patients 136
COVID-19 infection in patients on long-term home parenteral nutrition for chronic intestinal failure 135
Transition of patients with chronic intestinal failure from paediatric to adult center 135
Outcome on home parenteral nutrition for benign intestinal failure: A review of the literature and benchmarking with the European prospective survey of ESPEN. 134
ESPEN practical guideline: Clinical nutrition in chronic intestinal failure 134
Surgical approach to complicated intestinal failure for benign disease in adult patients: transplantation or surgical rehabilitation? 133
Malnutrition in hospitalized patients with SARS-CoV-2 infection 132
Value of immunonutrition in patients undergoing pancreatic resection: a trial sequential meta-analysis 132
Operative endoscopy for treatment of native rectal post-transplantation lymphoproliferative disease after adult small bowel transplantation: a case report 130
Steroids in intestinal transplantation 130
Role of citrulline in rejection monitoring after bowel transplantation 128
Mortality after steroid-resistant acute cellular rejection and chronic rejection episodes in adult intestinal transplants: report from a single center in induction/preconditioning era. 128
Corrigendum to "ESPEN guidelines on chronic intestinal failure in adults"[Clin Nutr 35 (2) (2016) 247–307] (S0261561416000479) (10.1016/j.clnu.2016.01.020) 128
Twenty-seven consecutive intestinal and multivisceral transplants in adult patients: a 4-year clinical experience. 128
Caloric input is inadequate in predicting the presence of liver steatosis and fibrosis in a population adhering to a screening program for metabolic syndrome 126
ESPEN guidelines on chronic intestinal failure in adults 126
Plasma citrullina in short bowel syndrome and intestinal transplantation 125
Endogenous ethanol production in a patient with chronic intestinal pseudo-obstruction and small intestinal bacterial overgrowth 125
Home parenteral nutrition provision modalities for chronic intestinal failure in adult patients: An international survey 125
Totale 17.390
Salva come PNG Salva come JPEG
Categoria #
all - tutte 77.002
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 77.002
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021695 0 0 0 0 0 0 0 0 0 140 97 458
2021/20222.692 153 123 215 160 260 147 91 231 130 130 553 499
2022/20232.786 280 406 133 349 229 221 86 154 491 97 195 145
2023/2024988 59 165 65 82 80 150 28 92 45 84 79 59
2024/20254.120 132 695 393 346 648 220 266 96 62 215 247 800
2025/20269.458 973 1.092 1.007 816 1.007 576 1.160 407 1.785 635 0 0
Totale 27.387